Drug Therapy Limited in Patients with Huntington’s Disease

被引:0
作者
机构
关键词
Clozapine; Atypical Antipsychotic; Selegiline; Riluzole; Tetrabenazine;
D O I
10.2165/00042310-199914120-00002
中图分类号
学科分类号
摘要
引用
收藏
页码:5 / 7
页数:2
相关论文
共 50 条
  • [21] Management of Huntington's disease: role of tetrabenazine
    de Tommaso, Marina
    Serpino, Claudia
    Sciruicchio, Vittorio
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2011, 7 : 123 - 129
  • [22] Investigational agents for the management of Huntington's disease
    Mueller, Thomas
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (02) : 175 - 185
  • [23] Advances in the Pharmacological Management of Huntington's Disease
    Frank, Samuel
    Jankovic, Joseph
    DRUGS, 2010, 70 (05) : 561 - 571
  • [24] Neuroprotective effects of riluzole in Huntington’s disease
    Ferdinando Squitieri
    Andrea Ciammola
    Claudio Colonnese
    Andrea Ciarmiello
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 221 - 222
  • [25] Tetrabenazine is neuroprotective in Huntington's disease mice
    Hongyu Wang
    Xi Chen
    Yuemei Li
    Tie-Shan Tang
    Ilya Bezprozvanny
    Molecular Neurodegeneration, 5
  • [26] Apraxia of eyelid closure in Huntington's disease
    Bonelli, RM
    Niederwieser, G
    JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (02) : 197 - 201
  • [27] Advances in the Pharmacological Management of Huntington’s Disease
    Samuel Frank
    Joseph Jankovic
    Drugs, 2010, 70 : 561 - 571
  • [28] TetrabenazineFor Chorea Associated with Huntington’s Disease
    Lesley J. Scott
    CNS Drugs, 2011, 25 : 1073 - 1085
  • [29] Antipsychotic Drug Binding in the Substantia Nigra: An Examination of High Metoclopramide Binding in the Brains of Normal, Alzheimer's Disease, Huntington's Disease, and Multiple Sclerosis Patients, and Its Relation to Tardive Dyskinesia
    Chen, Sheng
    Seeman, Philip
    Liu, Fang
    SYNAPSE, 2011, 65 (02) : 119 - 124
  • [30] Valbenazine for the treatment of chorea associated with Huntington's disease
    Patino, Jorge
    Furr Stimming, Erin
    Testa, Claudia M.
    Mehanna, Raja
    EXPERT OPINION ON PHARMACOTHERAPY, 2025, 26 (02) : 127 - 132